GlassScriptPhysician profile
Stephanie Morris
NPI 1245744986
$1,262.42
in general payments reported to CMS, 2019-2025
21 companies · $598 in 2025
The $598 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.08 · 2022: $192 · 2023: $285 · 2024: $130 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $166.90 | 2024-2025 | Urolift, Barrigel |
| Edwards Lifesciences Corporation | $148.08 | 2025 | |
| Boston Scientific Corporation | $120.89 | 2024-2025 | Lithovue, Spaceoar Vue System - 10ml, Ams 700 |
| Abbvie INC. | $120.20 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $92.52 | 2023-2024 | Gemtesa, Orgovyx |
| Ferring Pharmaceuticals INC. | $72.90 | 2023-2025 | Adstiladrin, Rebyota |
| Progenics Pharmaceuticals, INC. | $71.90 | 2023-2025 | Pylarify |
| Myovant Sciences INC. | $70.19 | 2022 | |
| Myriad Genetic Laboratories, INC. | $58.58 | 2025 | Prolaris |
| Dentsply Ih INC. | $58.08 | 2021 | |
| Convatec INC. | $57.89 | 2023 | |
| Astellas Pharma US INC | $46.34 | 2022 | |
| Blue Earth Diagnostics | $37.48 | 2025 | Posluma |
| Endo USA, INC. | $24.64 | 2025 | Xiaflex |
| Axonics, INC. | $24.57 | 2023 | Bulkamid |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $18.22 | 2025 | |
| Urovant Sciences INC | $17.81 | 2022 | |
| Olympus America INC. | $16.67 | 2025 | Itind System |
| Antares Pharma, INC. | $15.23 | 2022 | |
| Urogen Pharma, INC. | $11.80 | 2022 | |
| Laborie Medical Technologies Corp. | $11.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.